Abstract:Abstract A 15 year-old boy presented with a 2-year history of patches of hair loss on his body, and skin changes. Initial examination revealed scattered erythematous patches with associated follicular accentuation and concurrent nonscarring alopecia, predominantly affecting his limbs. His background included acne, gynaecomastia and exercise-induced asthma. His only regular medication was a salbutamol inhaler. Punch biopsies from the left shin and right arm demonstrated mild acanthosis of the epidermis with slight hyperkeratosis, focal parakeratosis and minimal spongiosis with occasional lymphocyte exocytosis. The initial biopsies were reported as nonspecific changes of lymphocytic folliculitis with spongiosis. Following clinicopathological review a diagnosis of alopecia mucinosa was considered. Further histopathological review confirmed spongiosis in the superficial to midpart of the hair follicle. Additionally noted was exocytosis of lymphocytes, which displayed subtle cytological atypia marked by nuclear irregularity and slight enlargement, and immunohistochemistry indicated a predominance of CD4+ T cells, raising the possibility of mycosis fungoides. Subsequent incisional biopsies were performed for T-cell clonality studies using the BIOMED-2 protocol and were polyclonal. Expert external histopathologist opinion was sought and this supported a diagnosis of folliculotropic mycosis fungoides (FMF), a condition rarely described in paediatric patients. The patient had patch-stage disease of his arms and legs with follicular accentuation and his modified Severity-Weighted Assessment Tool (mSWAT) score was 3.9. He had no lymphadenopathy or B symptoms. He was initiated on mometasone furoate 0.1% and his current management plan is for observation for clinical response and for further investigations, including lymphocyte subsets and high-throughput sequencing of the T-cell receptor, which are awaited. Although T-cell gene receptor rearrangement studies indicated polyclonality, their sensitivity is estimated at 50–70%. Based on the clinical and histological features the patient was diagnosed with stage IA FMF. FMF is characterized histologically by atypical CD4+ T lymphocytes that surround and infiltrate the hair follicles (folliculotropism) and should be considered in lesions resembling keratosis pilaris but in an unusual distribution and/or in clusters. Epidermotropism is typically absent in FMF, and concomitant follicular mucinosis is frequently observed. Paediatric follicular MF is rare, but this case highlights that in cases of suspected alopecia mucinosa, even in paediatric patients, a diagnosis of FMF merits careful consideration (Reiter O, Amitay-Laish I, Oren-Shabtai M et al. Paediatric mycosis fungoides – characteristics, management and outcomes with particular focus on the folliculotropic variant. J Eur Acad Dermatol Venereol 2022; 36: 671–9).

Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management

Mycosis fungoides: Current trends in diagnosis and management

When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses

Approach to Mycosis Fungoides in children (ARMFUL study): consensus-based recommendations

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management

Paediatric Mycosis Fungoides: Clinical Variants, Treatment Modalities and Response to Therapy

P068 A history of mycosis fungoides: from Alibert to mogamulizumab

H03 (P068) A history of mycosis fungoides: from Alibert to mogamulizumab

Five paediatric mycosis fungoides cases and our approach to provide age-appropriate information and psychological support

Correction To: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: an International Expert Panel Discussion.

PA13 A hair’s breadth from misdiagnosis

Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments

Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers

The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides

Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management

Skin-directed therapy and biologic response modifiers in mycosis fungoides

Phototherapy and mycosis fungoides: what's new?

Primary cutaneous follicle center lymphoma in a 16‐year‐old girl

Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression

A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab